SGLT2 inhibitors may offer benefit beyond diabetes von Kang, Amy, Jardine, Meg J.

Volltext

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis... von Toyama, Tadashi, Neuen, Brendon L., Jun, Min, Ohkuma, Toshiaki, Neal, Bruce, Jardine, Meg J., Heerspink, Hiddo L., Wong, Muh Geot, Ninomiya, Toshiharu, Wada, Takashi, Perkovic, Vlado

Volltext

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects von Heerspink, Hiddo J L, Desai, Mehul, Jardine, Meg, Balis, Dainius, Meininger, Gary, Perkovic, Vlado

Volltext

Burden of Care and Quality of Life Among Caregivers for Adults Receiving Maintenance Dialysis: A Systematic Review von Gilbertson, Elise L., Krishnasamy, Rathika, Foote, Celine, Kennard, Alice L., Jardine, Meg J., Gray, Nicholas A.

Volltext

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis von Neuen, Brendon L, Young, Tamara, Heerspink, Hiddo J L, Neal, Bruce, Perkovic, Vlado, Billot, Laurent, Mahaffey, Kenneth W, Charytan, David M, Wheeler, David C, Arnott, Clare, Bompoint, Severine, Levin, Adeera, Jardine, Meg J

Volltext

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis von Arnott, Clare, Li, Qiang, Kang, Amy, Neuen, Brendon L, Bompoint, Severine, Lam, Carolyn S P, Rodgers, Anthony, Mahaffey, Kenneth W, Cannon, Christopher P, Perkovic, Vlado, Jardine, Meg J, Neal, Bruce

Volltext

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics von Jardine, Meg J., Mahaffey, Kenneth W., Neal, Bruce, Agarwal, Rajiv, Bakris, George L., Brenner, Barry M., Bull, Scott, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Heerspink, Hiddo J.L., Levin, Adeera, Pollock, Carol, Wheeler, David C., Xie, John, Zhang, Hong, Zinman, Bernard, Desai, Mehul, Perkovic, Vlado

Volltext

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial von Jardine, Meg J, Zhou, Zien, Mahaffey, Kenneth W, Oshima, Megumi, Agarwal, Rajiv, Bakris, George, Bajaj, Harpreet S, Bull, Scott, Cannon, Christopher P, Charytan, David M, de Zeeuw, Dick, Di Tanna, Gian Luca, Greene, Tom, Heerspink, Hiddo J L, Levin, Adeera, Neal, Bruce, Pollock, Carol, Qiu, Rose, Sun, Tao, Wheeler, David C, Zhang, Hong, Zinman, Bernard, Rosenthal, Norman, Perkovic, Vlado

Volltext

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program von Neuen, Brendon L, Ohkuma, Toshiaki, Neal, Bruce, Matthews, David R, de Zeeuw, Dick, Mahaffey, Kenneth W, Fulcher, Greg, Desai, Mehul, Li, Qiang, Deng, Hsiaowei, Rosenthal, Norm, Jardine, Meg J, Bakris, George, Perkovic, Vlado

Volltext

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial von Lv, Jicheng, Zhang, Hong, Wong, Muh Geot, Jardine, Meg J, Hladunewich, Michelle, Jha, Vivek, Monaghan, Helen, Zhao, Minghui, Barbour, Sean, Reich, Heather, Cattran, Daniel, Glassock, Richard, Levin, Adeera, Wheeler, David, Woodward, Mark, Billot, Laurent, Chan, Tak Mao, Liu, Zhi-Hong, Johnson, David W, Cass, Alan, Feehally, John, Floege, Jürgen, Remuzzi, Giuseppe, Wu, Yangfeng, Agarwal, Rajiv, Wang, Hai-Yan, Perkovic, Vlado

Volltext

SGLT2 inhibitors and finerenone: one or the other or both? von Neuen, Brendon L, Jardine, Meg J

Volltext

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial von Oshima, Megumi, Neuen, Brendon L, Li, JingWei, Perkovic, Vlado, Charytan, David M, de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Mahaffey, Kenneth W, De Nicola, Luca, Pollock, Carol, Rosenthal, Norman, Wheeler, David C, Jardine, Meg J, Heerspink, Hiddo J L

Volltext

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy von Levin, Adeera, Dr, Tonelli, Marcello, MD, Bonventre, Joseph, MD, Coresh, Josef, PhD, Donner, Jo-Ann, MLT, Fogo, Agnes B, MD, Fox, Caroline S, MD, Gansevoort, Ron T, PhD, Heerspink, Hiddo J L, PhD, Jardine, Meg, PhD, Kasiske, Bertram, MD, Köttgen, Anna, MD, Kretzler, Matthias, MD, Levey, Andrew S, MD, Luyckx, Valerie A, MBBCh, Mehta, Ravindra, MD, Moe, Orson, MD, Obrador, Gregorio, MPH, Pannu, Neesh, MD, Parikh, Chirag R, PhD, Perkovic, Vlado, PhD, Pollock, Carol, PhD, Stenvinkel, Peter, MD, Tuttle, Katherine R, MD, Wheeler, David C, MD, Eckardt, Kai-Uwe, MD

Volltext

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study von Jun, Min, Jardine, Meg J, Perkovic, Vlado, Pilard, Quentin, Billot, Laurent, Rodgers, Anthony, Rogers, Kris, Gallagher, Martin

Volltext

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice von Oshima, Megumi, Jardine, Meg J., Agarwal, Rajiv, Bakris, George, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Lim, Soo Kun, Mahaffey, Kenneth W., Neal, Bruce, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Perkovic, Vlado, Heerspink, Hiddo J.L.

Volltext

Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial von Neuen, Brendon L, Oshima, Megumi, Perkovic, Vlado, Agarwal, Rajiv, Arnott, Clare, Bakris, George, Cannon, Christopher P, Charytan, David M, Edwards, Robert, Górriz, Jose L, Jardine, Meg J, Levin, Adeera, Neal, Bruce, De Nicola, Luca, Pollock, Carol, Rosenthal, Norman, Wheeler, David C, Mahaffey, Kenneth W, Heerspink, Hiddo J L

Volltext

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis von Hou, Wanyin, Lv, Jicheng, Perkovic, Vlado, Yang, Lihong, Zhao, Na, Jardine, Meg J, Cass, Alan, Zhang, Hong, Wang, Haiyan

Volltext

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future? von Neuen, Brendon L, Jardine, Meg J, Perkovic, Vlado

Volltext

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Includi... von Cannon, Christopher P., Perkovic, Vlado, Agarwal, Rajiv, Baldassarre, James, Bakris, George, Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Heerspink, Hiddo J.L., Jardine, Meg J., Levin, Adeera, Li, Jing-Wei, Neal, Bruce, Pollock, Carol, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Mahaffey, Kenneth W.

Volltext

Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks—A Narrative Review von Clase, Catherine M., Fu, Edouard L., Ashur, Aurneen, Beale, Rupert C.L., Clase, Imogen A., Dolovich, Myrna B., Jardine, Meg J., Joseph, Meera, Kansiime, Grace, Mann, Johannes F.E., Pecoits-Filho, Roberto, Winkelmayer, Wolfgang C., Carrero, Juan J.

Volltext